Literature DB >> 15702426

[Fibromyalgia in the legal procedures of the german sozialgericht -- psychosocial risk factors and predictors of health care utilization].

Winfried Häuser1.   

Abstract

Retrospectively all consecutive medical expertise within the appraisal of early retirement/occupational disability or of the status of a severely disabled person in 88 people (85 % female) diagnosed with fibromyalgia who were investigated by a structured pain therapist's and psychotherapeutic assessment were analysed. 44 % had a history of psychiatric disorder, 85 % met the criteria of a current psychiatric disorder according ICD-10. 8 % indicated sexual abuse, 16 % severe physical abuse in childhood or adulthood and 13 % emotional deprivation in the childhood. A preponderance of belonging to lower class compared to the general German population was noted. Former and current psychiatric disorders, biographic adverse experiences, duration of generalized pain, age, sex and social class had no substantial predictive value on the extensive health care utilization (number of doctors, pain-related hospital and rehabilitation stays and pain-related operations).

Entities:  

Mesh:

Year:  2005        PMID: 15702426     DOI: 10.1055/s-2004-828508

Source DB:  PubMed          Journal:  Psychother Psychosom Med Psychol        ISSN: 0937-2032


  6 in total

1.  [High utilization of health care services by fibromyalgia patients].

Authors:  S Horndasch
Journal:  Schmerz       Date:  2009-02       Impact factor: 1.107

2.  [Definition, classification and diagnosis of fibromyalgia syndrome].

Authors:  W Eich; W Häuser; E Friedel; A Klement; M Herrmann; F Petzke; M Offenbächer; M Schiltenwolf; C Sommer; T Tölle; P Henningsen
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

3.  [Causal illness attributions and healthcare utilization in fibromyalgia syndrome].

Authors:  W Häuser; R Wilhelm; W Klein; C Zimmer
Journal:  Schmerz       Date:  2006-04       Impact factor: 1.107

4.  [Fibromyalgia -- a somatoform (pain) disorder?].

Authors:  W Häuser; K Bernardy; B Arnold
Journal:  Schmerz       Date:  2006-04       Impact factor: 1.107

5.  [German fibromyalgia consumer reports. Benefits and harms of fibromyalgia syndrome therapies].

Authors:  W Häuser; E Jung; B Erbslöh-Möller; M Gesmann; H Kühn-Becker; F Petermann; J Langhorst; T Weiss; R Thoma; A Winkelmann
Journal:  Schmerz       Date:  2012-04       Impact factor: 1.107

6.  [Aims of the guidelines for diagnostic and treatment of fibromyalgia syndrome].

Authors:  M Schiltenwolf; W Eich; R Schmale-Grete; W Häuser
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.